Skip to main content
Clinical Trials/CTRI/2020/04/024460
CTRI/2020/04/024460
Recruiting
Phase 3

A randomized controlled trial to assess the incidence of lymphedema in women with breast cancer undergoing sentinel lymph node biopsy or low axillary sampling. (AiSLe) - AiSLe

Tata Memorial Centre0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Sponsor
Tata Memorial Centre
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Clinically node negative early breast cancer planned for upfront surgery
  • 2\. All eligible women who are willing to give informed consent.

Exclusion Criteria

  • 1\.Previous axillary surgery
  • 2\.Post neoadjuvant therapy (chemotherapy/ hormone therapy)
  • 3\.Pre\-existing lymphedema
  • 4\.Previous h/o radiation to axilla
  • 5\.Previous h/o granulomatous lymphadenitis in axilla
  • 6\.Allergy to the dye

Outcomes

Primary Outcomes

Not specified

Similar Trials